-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
Prevalence of elevated lipoprotein(a) levels in Korean: A large population-based study
Rihwa Choi, Mi-Jung Park, Youngju Oh, Sukjung Lee, Sung Ho Kim, Sang Gon Lee, and Eun Hee Lee
Short Communication: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
A comparison of liprotamase, a non-porcine pancreatic enzyme replacement therapy, to porcine extracted pancrelipase in a noninferiority randomized clinical trial in patients with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Michael Wilschanski, István Laki, Steven R Boas, Dorota Sands, Monica Gangal, Renee S Martin, William Shanahan, James Pennington
Research Article: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Outcome measures in amyotrophic lateral sclerosis clinical trials
Sabrina Paganoni, Merit Cudkowicz, James D Berry
Clinical Trail Methodology: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
Missing data in clinical trials: a data interpretation problem with statistical solutions? Interview with James Roger
James Roger
Interview: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
A time for hope - new metastatic melanoma agent astounds at the ASCO
News and Views: Clinical Investigation
-
Belimumab receives US FDA approval for treatment of systemic lupus
News and Views: Clinical Investigation
-
Belimumab receives US FDA approval for treatment of systemic lupus
News and Views: Clinical Investigation
-
Belimumab receives US FDA approval for treatment of systemic lupus
News and Views: Clinical Investigation
-
Belimumab receives US FDA approval for treatment of systemic lupus
News and Views: Clinical Investigation
-
Belimumab receives US FDA approval for treatment of systemic lupus
News and Views: Clinical Investigation
-
Belimumab receives US FDA approval for treatment of systemic lupus
News and Views: Clinical Investigation
-
Belimumab receives US FDA approval for treatment of systemic lupus
News and Views: Clinical Investigation
-
Belimumab receives US FDA approval for treatment of systemic lupus
News and Views: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation